Logo image of AREB

AMERICAN REBEL HOLDINGS INC (AREB) Stock Fundamental Analysis

NASDAQ:AREB - Nasdaq - US02919L6048 - Common Stock - Currency: USD

1.31  -0.07 (-5.07%)

After market: 1.3016 -0.01 (-0.64%)

Fundamental Rating

1

Taking everything into account, AREB scores 1 out of 10 in our fundamental rating. AREB was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of AREB have multiple concerns. AREB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AREB has reported negative net income.
In the past year AREB has reported a negative cash flow from operations.
AREB had negative earnings in each of the past 5 years.
AREB had a negative operating cash flow in each of the past 5 years.
AREB Yearly Net Income VS EBIT VS OCF VS FCFAREB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of AREB (-205.69%) is worse than 96.39% of its industry peers.
Industry RankSector Rank
ROA -205.69%
ROE N/A
ROIC N/A
ROA(3y)-101.11%
ROA(5y)-293.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AREB Yearly ROA, ROE, ROICAREB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

AREB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AREB Yearly Profit, Operating, Gross MarginsAREB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

0

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AREB has been increased compared to 1 year ago.
The number of shares outstanding for AREB has been increased compared to 5 years ago.
AREB has a worse debt/assets ratio than last year.
AREB Yearly Shares OutstandingAREB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K
AREB Yearly Total Debt VS Total AssetsAREB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -14.35, we must say that AREB is in the distress zone and has some risk of bankruptcy.
AREB has a Altman-Z score of -14.35. This is amonst the worse of the industry: AREB underperforms 93.98% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.35
ROIC/WACCN/A
WACC7.89%
AREB Yearly LT Debt VS Equity VS FCFAREB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

AREB has a Current Ratio of 0.40. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.40, AREB is not doing good in the industry: 93.98% of the companies in the same industry are doing better.
AREB has a Quick Ratio of 0.40. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.13, AREB is not doing good in the industry: 96.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.13
AREB Yearly Current Assets VS Current LiabilitesAREB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.66% over the past year.
The Revenue for AREB has decreased by -36.78% in the past year. This is quite bad
AREB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 84.10% yearly.
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.62%
Revenue 1Y (TTM)-36.78%
Revenue growth 3Y125.95%
Revenue growth 5Y84.1%
Sales Q2Q%-37.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREB Yearly Revenue VS EstimatesAREB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AREB Yearly EPS VS EstimatesAREB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AREB Price Earnings VS Forward Price EarningsAREB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AREB Per share dataAREB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300 -400

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AREB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (7/11/2025, 8:00:00 PM)

After market: 1.3016 -0.01 (-0.64%)

1.31

-0.07 (-5.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-12 2025-08-12
Inst Owners0.84%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change8.09%
Market Cap8.57M
Analysts82.86
Price TargetN/A
Short Float %8.58%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-431.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS1.51
BVpS-1.23
TBVpS-1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -205.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-101.11%
ROA(5y)-293.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.13
Altman-Z -14.35
F-Score2
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)15.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.78%
Revenue growth 3Y125.95%
Revenue growth 5Y84.1%
Sales Q2Q%-37.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.02%
OCF growth 3YN/A
OCF growth 5YN/A